Helicobacter pylori and gastric mucosal factors

This entry represents a non-specific category of therapeutic targets within the gastric environment, primarily involving the pathogen Helicobacter pylori and local physiological factors like gastric acid and the mucosal barrier. Helicobacter pylori is a Gram-negative bacterium that colonizes the stomach, leading to chronic inflammation, peptic ulcers, and an increased risk of gastric adenocarcinoma (StatPearls, 2023). Gastric mucosal factors include the protective mucus-bicarbonate layer and the hydrochloric acid secreted by parietal cells, which maintain the stomach's low pH. Drugs interacting with these components often employ non-specific mechanisms: antacids provide direct chemical neutralization of gastric acid, while sucralfate acts by forming a cytoprotective physical barrier over damaged mucosa (StatPearls, 2023). Bismuth salts provide multi-targeted antimicrobial effects against H. pylori, including cell wall disruption and enzyme inhibition, while also enhancing mucosal protective factors (StatPearls, 2022). Because this classification encompasses both a complex organism and various chemical/physical processes in the stomach, it is considered a non-specific or aggregate classification rather than a distinct molecular target.

Other names

Gastric mucosal componentsHelicobacter pylori componentsLocal gastric factorsGastric acid and H. pylori

Neutralization of gastric acid, formation of protective mucosal barriers, and non-specific antimicrobial activity against H. pylori.